HCPCS Level IIdrugActive
J0895
Deferoxamine mesylate inj
BETOS: O1E
Effective: 2001-01-01
Referenced in 4 policies
Description
Injection, deferoxamine mesylate, 500 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Desferal
Manufacturer
Novartis Pharmaceuticals Corporation
HCPCS Dosage
500 MG
Billing Units
1.0000
6
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.